| abstract |
The present disclosure relates to compounds that are sodium channel inhibitors and their use in the treatment of various disease states including cardiovascular diseases and diabetes. In certain embodiments, the structure of a compound is represented by Formula I: Wherein Y, Z, n, R 1 and R 3 are as described herein. The present disclosure also relates to methods of making the compounds and pharmaceutical compositions containing the compounds. |